M. Boffito

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

K. Y. Wong, Mohammad A. Qayum, John S. Clouston, 2022, Lancet.

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

K. Y. Wong, Beverley E. Crane, Scott M Elliott, 2021, Lancet.

A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitors

L. Waters, M. Boffito, M. Nelson, 2016, HIV clinical trials.

Screening for HIV-related neurocognitive impairment in clinical practice: Challenges and opportunities

J. Catalan, M. Boffito, B. Gazzard, 2014, AIDS care.

Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study

B. Gazzard, G. Moyle, D. Asboe, 2017, International journal of STD & AIDS.